HIV/AIDS
485
26
41
348
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
130 trials with published results (27%)
Research Maturity
348 completed trials (72% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.9%
14 terminated out of 485 trials
96.1%
+9.5% vs benchmark
6%
27 trials in Phase 3/4
37%
130 of 348 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 348 completed trials
Clinical Trials (485)
ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
Observational Pharmaco-Epidemiology Research & Analysis
Characteristics and Outcomes of Patients Who Received Etravirine and/or Darunavir
Optimizing Tobacco Use Treatment for PLWHA
Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.
Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Randomized Trial
Combinatorial Therapy to Induce an HIV Remission
An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing
Robot-Assisted Rehabilitation After HIV-Associated Stroke: Botswana
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
Hispanic Men Building Respect Education and Safety/ HoMBRES Manteniendo Respeto, Educacion y Seguridad.
Impact of HIV-1 and Aging on Mucosal Vaccine Responses
Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)
Integration of Hypertension Management in HIV Care in Uganda
Targeted Universal TB Testing With Simultaneous TPT Prescribing Among People Living With HIV in South Africa
Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes (Philani Ndiphile)
The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)
INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)